Evidence map›Paper›PMID 35087210›Full record

ArticleCommunications biology2022

Docking-guided rational engineering of a macrolide glycosyltransferase glycodiversifies epothilone B.

Peng Zhang, Lijuan Zhang, Xukai Jiang, Xiao-Tong Diao, Shuang Li, Dan-Dan Li, Zheng Zhang, Junqiang Fang, Ya-Jie Tang, Da-Lei Wu and 2 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Peng ZhangState Key Laboratory of Microbial Technology, Institute of Microbial Technology, Shandong University, Qingdao, 266237, P.R. China.
Lijuan ZhangState Key Laboratory of Microbial Technology, Institute of Microbial Technology, Shandong University, Qingdao, 266237, P.R. China.
Xukai JiangNational Glycoengineering Research Center, Shandong Provincial Key Laboratory of Glycochemistry and Glycobiology, Shandong University, Qingdao, Shandong, 266237, P.R. China.ORCID http://orcid.org/0000-0002-3624-8732
Xiao-Tong DiaoState Key Laboratory of Microbial Technology, Institute of Microbial Technology, Shandong University, Qingdao, 266237, P.R. China.
Shuang LiNational Glycoengineering Research Center, Shandong Provincial Key Laboratory of Glycochemistry and Glycobiology, Shandong University, Qingdao, Shandong, 266237, P.R. China.
Dan-Dan LiState Key Laboratory of Microbial Technology, Institute of Microbial Technology, Shandong University, Qingdao, 266237, P.R. China.
Zheng ZhangState Key Laboratory of Microbial Technology, Institute of Microbial Technology, Shandong University, Qingdao, 266237, P.R. China.
Junqiang FangNational Glycoengineering Research Center, Shandong Provincial Key Laboratory of Glycochemistry and Glycobiology, Shandong University, Qingdao, Shandong, 266237, P.R. China.
Ya-Jie TangState Key Laboratory of Microbial Technology, Institute of Microbial Technology, Shandong University, Qingdao, 266237, P.R. China.
Da-Lei WuState Key Laboratory of Microbial Technology, Institute of Microbial Technology, Shandong University, Qingdao, 266237, P.R. China.ORCID http://orcid.org/0000-0003-1817-7229
Changsheng WuState Key Laboratory of Microbial Technology, Institute of Microbial Technology, Shandong University, Qingdao, 266237, P.R. China. wuchangsheng@sdu.edu.cn.ORCID http://orcid.org/0000-0003-1310-0089
Yue-Zhong LiState Key Laboratory of Microbial Technology, Institute of Microbial Technology, Shandong University, Qingdao, 266237, P.R. China. lilab@sdu.edu.cn.ORCID http://orcid.org/0000-0001-8336-6638
Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycosyltransferases typically display acceptor substrate flexibility but more stringent donor specificity. BsGT-1 is a highly effective glycosyltransferase to glycosylate macrolides, including epothilones, promising antitumor compounds. Here, we show that BsGT-1 has three major regions significantly influencing the glycodiversification of epothilone B based on structural molecular docking, "hot spots" alanine scanning, and site saturation mutagenesis. Mutations in the PSPG-like motif region and the C2 loop region are more likely to expand donor preference; mutations of the flexible N3 loop region located at the mouth of the substrate-binding cavity produce novel epothilone oligosaccharides. These "hot spots" also functioned in homologues of BsGT-1. The glycosides showed significantly enhanced water solubility and decreased cytotoxicity, although the glycosyl appendages of epothilone B also reduced drug permeability and attenuated antitumor efficacy. This study laid a foundation for the rational engineering of other GTs to synthesize valuable small molecules.

Indexed as

Amino Acid MotifsAmino Acid SequenceEpothilonesGene Expression Regulation, EnzymologicGlucosyltransferasesHepatocytesHep G2 CellsHumansMolecular Docking SimulationMutationProtein Engineeringepothilone BEpothilonesGlucosyltransferasesmacrolide glycosyltransferase

Identifiers

PMID35087210
PMCPMC8795383
OpenAlexW4210482838

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.